CSRXP: HOUSE MARKUPS ADD TO UNPRECEDENTED MOMENTUM TO HOLD BIG PHARMA ACCOUNTABLE
Sep 14, 2021
Committee Leaders Put Forward Solutions to Lower Prescription Drug Prices for… Read More
© 2026 CSRXP- All Rights Reserved
Updates
CSRXP APPLAUDS RELEASE OF HHS PLAN TO LOWER PRESCRIPTION DRUG PRICES AND HOLD BIG PHARMA ACCOUNTABLE
Sep 9, 2021
Administration Proposal Would Increase Competition, Transparency and Value —… Read More
CSRXP APPLAUDS PRESIDENT BIDEN’S COMMITMENT TO LOWERING PRESCRIPTION DRUG PRICES AND CALL FOR CONGRESS TO ACT
Aug 12, 2021
Speech Adds to Unprecedented Momentum for Action, Now Lawmakers Must Deliver… Read More
CSRXP STATEMENT ON U.S. SENATE PASSAGE OF REBATE RULE DELAY & REFUND ACT AS PART OF BIPARTISAN INFRASTRUCTURE BILL
Aug 10, 2021
Lawmakers Must Build on Momentum For Action With Permanent Repeal of Rebate… Read More
SECOND OPINION: BIG PHARMA TROTS OUT BOGUS R&D DEFENSE TO OPPOSE TAX
Aug 9, 2021
Remembering Drug Companies Spend Their Profits on Shareholders and Marketing… Read More
BIG PHARMA EARNINGS WATCH: ASTRAZENECA, SANOFI, MERCK, ABBVIE, ELI LILLY & AMGEN
Aug 6, 2021
Q2 Earnings Reports Continue to Show Pandemic Price Hikes Profitable for Brand… Read More
BIG PHARMA EARNINGS WATCH: PFIZER, GLAXO SMITH KLINE, BRISTOL MYERS SQUIBB
Jul 30, 2021
Big Pharma Companies Continue to Rake in Massive Profits After Three Rounds of… Read More
CSRXP WELCOMES FDA APPROVAL OF FIRST INTERCHANGEABLE BIOLOGIC FOR INSULIN
Jul 29, 2021
Interchangeable Products Will Help Increase Prescription Drug Competition and… Read More
CSRXP: SENATE JUDICIARY COMMITTEE CRACKS DOWN ON BIG PHARMA PATENT ABUSE
Jul 29, 2021
Unanimous, Bipartisan Passage of Bills Targeting Brand Name Drug Companies’… Read More
BIG PHARMA EARNINGS WATCH: JOHNSON & JOHNSON, NOVARTIS, ROCHE
Jul 22, 2021
New Round of Earnings Reports Show Big Pharma Companies Riding High on Massive… Read More
SECOND OPINION: PHARMA-BACKED REBATE RULE WOULD HIKE SENIOR PREMIUMS, BOOST DRUG COMPANY PROFITS
Jul 22, 2021
Big Pharma Wants Implementation of Misguided Policy that Does Nothing to Lower… Read More
THEY SAID IT! U.S. SENATE JUDICIARY SUBCOMMITTEE HIGHLIGHTS BIG PHARMA’S ANTI-COMPETITIVE PRACTICES
Jul 14, 2021
Lawmakers Showcase How Big Pharma’s Patent Abuse Drives Out-of-Control… Read More